2017PubMedRequires access

AAN Updates Guidelines on the Uses of Botulinum Neurotoxin.

Jennifer Wilkes

Open publisher page 6 citations

Abstract

In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights updates on four indications: blepharospasm, cervical dystonia, spasticity in adults, and headache.

About this research paper

What this paper is about

In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights updates on four indications: blepharospasm, cervical dystonia, spasticity in adults, and headache.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights updates on four indications: blepharospasm, cervical dystonia, spasticity in adults, and headache.

Key concepts: Blepharospasm, Cervical dystonia, Medicine, Botulinum neurotoxin, Botulinum toxin, Dystonia, Spasticity, Neurotoxin

Related papers

Back to paper searchBrowse research topicsOriginal source
AAN Updates Guidelines on the Uses of Botulinum Neurotoxin. — Research Paper | ScholarLens